Floatz logo

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril

Cerebral Microbleeding

Zhejiang Provincial People's HospitalSmall moleculePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Cerebral Microbleeding cohort.

Asset / SponsorPhaseRating
WARFARIN
Seoul National University Hospital
Phase 4BBB
Acetylsalicylic Acid
Peking Union Medical College Hospital
Phase 3BB
Lipitor
Sichuan Provincial People's Hospital
Phase 4BB
Plavix
Peking Union Medical College Hospital
Phase 3BB
Tenecteplase
University of Melbourne
Phase 3BB

View all 37 →

Same molecule, other indications

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril is also rated in:

cerebral infarctionDormant
BBB
Indicative ·
79 / 100
View asset →
transient ischemic attackDormant
BBB
Indicative ·
75 / 100
View asset →
ischemic strokeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →